Core Insights - Fangzhou Inc. and Tencent Healthcare have launched an "AI+Chronic Disease Management" solution, enhancing the integration of AI in China's healthcare sector [1][4][7] - The solution leverages Fangzhou's AI+H2H ecosystem and Tencent Cloud's technological capabilities, aiming to improve chronic disease management efficiency [2][6] - The partnership aligns with national health guidelines and supports the "Healthy China 2030" initiative, promoting digital transformation in healthcare [7] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, with 52.8 million registered users and 229,000 physicians as of June 30, 2025 [9] - The company specializes in AI-enabled precision medicine solutions and tailored medical care [9] Technological Framework - The solution is built on a robust technological foundation, utilizing Tencent Healthcare's TI platform for model training, evaluation, and deployment [6] - Tencent's vector database enhances the accuracy of medical knowledge retrieval, supporting the AI's factual outputs [6] Safety and Compliance - Fangzhou has implemented multiple safety measures to mitigate AI hallucinations in clinical settings, including reinforcement learning and rule-based supervision [5][6] - Compliance with regulatory standards for clinical AI is ensured through Tencent Healthcare's AI security measures [6]